Montaner JS - Search Results

1

HIV treatment as prevention among injection drug users.

Wood E, Milloy MJ, Montaner JS. Wood E, et al. Among authors: montaner js. Curr Opin HIV AIDS. 2012 Mar;7(2):151-6. doi: 10.1097/COH.0b013e32834f9927. Curr Opin HIV AIDS. 2012. PMID: 22227587 Review.

2

The T cell receptor V beta repertoire shows little change during treatment interruption-related viral rebound in chronic HIV infection.

Grant M, Pardoe I, Whaley M, Montaner JS, Harrigan PR. Grant M, et al. Among authors: montaner js. AIDS. 2002 Jan 25;16(2):287-90. doi: 10.1097/00002030-200201250-00019. AIDS. 2002. PMID: 11807314

3

Case series assessing the safety of mycophenolate as part of multidrug rescue treatment regimens.

Press N, Kimel G, Harris M, Yip B, Craib KJ, Montaner JS. Press N, et al. Among authors: montaner js. HIV Clin Trials. 2002 Jan-Feb;3(1):17-20. doi: 10.1310/B6T0-N98J-1J3M-EQPK. HIV Clin Trials. 2002. PMID: 11819181 Clinical Trial.

4

Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme.

Wood E, Tyndall MW, Spittal PM, Li K, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT. Wood E, et al. Among authors: montaner js. AIDS. 2002 Apr 12;16(6):941-3. doi: 10.1097/00002030-200204120-00021. AIDS. 2002. PMID: 11919503

5

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up.

Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, Montaner JS. Hogg RS, et al. Among authors: montaner js. AIDS. 2002 May 3;16(7):1051-8. doi: 10.1097/00002030-200205030-00012. AIDS. 2002. PMID: 11953472

6

Prescribing practices in a population-based HIV postexposure prophylaxis program.

Braitstein P, Chan K, Beardsell A, McLeod A, Montaner JS, O'Shaughnessy MV, Hogg RS. Braitstein P, et al. Among authors: montaner js. AIDS. 2002 May 3;16(7):1067-70. doi: 10.1097/00002030-200205030-00014. AIDS. 2002. PMID: 11953474

7

"Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy.

Wood E, Hogg RS, Yip B, Tyndall MW, Sherlock CH, Harrigan RP, O'Shaughnessy MV, Montaner JS. Wood E, et al. Among authors: montaner js. J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):159-66. doi: 10.1097/00042560-200206010-00004. J Acquir Immune Defic Syndr. 2002. PMID: 12045678 Clinical Trial.

8

Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based chort.

Heath KV, Hogg RS, Singer J, Chan KJ, O'Shaughnessy MV, Montaner JS. Heath KV, et al. Among authors: montaner js. J Acquir Immune Defic Syndr. 2002 Aug 1;30(4):440-7. doi: 10.1097/00042560-200208010-00010. J Acquir Immune Defic Syndr. 2002. PMID: 12138351

9

Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.

Miller CL, Johnston C, Spittal PM, Li K, Laliberté N, Montaner JS, Schechter MT. Miller CL, et al. Among authors: montaner js. Hepatology. 2002 Sep;36(3):737-42. doi: 10.1053/jhep.2002.35065. Hepatology. 2002. PMID: 12198668

10

No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy.

Brumme ZL, Chan KJ, Dong WW, Mo T, Wynhoven B, Hogg RS, Montaner JS, O'Shaughnessy MV, Harrigan PR. Brumme ZL, et al. Among authors: montaner js. AIDS. 2002 Sep 27;16(14):1929-33. doi: 10.1097/00002030-200209270-00010. AIDS. 2002. PMID: 12351953

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

822 results

Search Page

Filters